Quantcast

Latest light therapy Stories

2014-10-21 23:12:37

FACE Skincare Medical Wellness founder, Holly CaSaroll, is excited to introduce a menu of celebrity-inspired facial treatments in the greater Detroit, MI area. Detroit, MI (PRWEB) October 21, 2014 Celebrities have always been the ones to seek and have access to the most advanced facial treatments. Skin management expert™, Holly CaSaroll, is excited to introduce a full menu of the most advanced facial treatments in the country, not just for celebrities. “We are in a new day and age...

2014-10-14 08:33:18

SAN RAFAEL, Calif., Oct. 14, 2014 /PRNewswire/ -- Sanovas Inc., a Life Science company accelerating the development and commercialization of next-generation microinvasive diagnostics, devices and drug delivery technologies, announced today that US Patent No. 8,834,544 has issued to the Company. Photo - http://photos.prnewswire.com/prnh/20141013/151744 Logo - http://photos.prnewswire.com/prnh/20141013/151743LOGO The patent, entitled "Photodynamic Therapy for Tumors...

2014-10-07 08:28:48

University of Mannheim Medical Center is first site opened TORONTO and CHICAGO, Oct. 7, 2014 /PRNewswire/ - Pinnacle Biologics, Inc. ("Pinnacle"), a subsidiary of Concordia Healthcare Corp., ("Concordia") (TSX: CXR) (OTCQX: CHEHF), announced today the initiation of the pivotal Phase 3 trial (OPUS) in Germany for a rare form of bile duct cancer for which there is currently no acceptable therapy. OPUS is an Open-label, multicenter phase 3 on the efficacy and safety of Photodynamic...

skin repigmentation
2014-09-19 02:00:01

David Olejarz, Henry Ford Health System A treatment regimen is safe and effective for restoring skin pigmentation in vitiligo patients, according to a Henry Ford Hospital study. “Our findings offer patients with vitiligo worldwide a renewed hope for a bright future in the treatment of this disfiguring disease,” says Henry Lim, M.D., chair of Dermatology at Henry Ford and the study’s lead author. “Patients with lesions on their face and arms could have a more rapid response to...

2014-09-17 08:28:52

Pivotal Phase 3 Clinical Trial Targeted to Begin in First Half of 2015 PRINCETON, N.J., Sept. 17, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that agreement has been reached with the US Food and Drug Administration (FDA) on the design of a pivotal, Phase 3 clinical trial evaluating its...

2014-09-15 23:01:28

Ondine's President and Chief Technology Officer Dr. Nicolas Loebel will be presenting at the 10th International Symposium on Photodynamic Therapy & Photodiagnosis in Clinical Practice Vancouver, BC (PRWEB) September 15, 2014 Ondine Biomedical Inc. is pleased to announce that Dr. Nicolas Loebel, its President and Chief Technology Officer, will be presenting at the 10th International Symposium on Photodynamic Therapy (PDT) and Photodiagnosis in Clinical Practice. The 2014 Symposium,...

2014-09-12 12:25:28

Laser Approved for Treatment of PCV, CSR CLERMONT-FERRAND, France, Sept. 12, 2014 /PRNewswire/ -- Quantel Medical today announced CE Mark approval for its Vitra(TM) PDT photodynamic therapy laser platform, for the treatment of polypoidal choroidal vasculopathy (PCV) and central serous retinopathy (CSR). Quantel, the sole manufacturer of this laser technology, plans to begin commercializing the laser platform immediately in countries requiring CE registration. PCV, a disease of the...

2014-09-10 23:11:43

Lexington Int’l is pleased to announce the publication of the results of a clinical review with the HairMax LaserComb in a peer-review medical journal, validating efficacy for treating hereditary hair loss. Boca Raton, FL (PRWEB) September 10, 2014 Lexington Int’l is pleased to announce the publication of the results of a clinical review with the HairMax LaserComb for the treatment of hair loss, in the peer-review medical journal, the International Journal of Trichology in the April...

2014-09-05 08:23:11

Newly Acquired SGX301 Orphan Drug Candidate Being Evaluated for Treatment of Cutaneous T-Cell Lymphoma PRINCETON, N.J., Sept. 5, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today the acquisition of a novel orphan drug candidate, known as SGX301 (synthetic hypericin). SGX301 is poised to enter...

2014-09-02 12:30:15

Sodrec Medical Solutions, Inc. to Partner for US Sales TUSTIN, Calif., Sept. 2, 2014 /PRNewswire/ -- BioPhotas, Inc. today announced the launch of the Celluma ELITE for sale to the Aesthetic Physician Market. The LED therapy device is stand-mounted and able to be precisely positioned over an area of treatment via an articulating arm and a patented shape-taking light panel. Sodrec Medical Solutions, Inc. will be responsible for all US promotion of the Celluma ELITE and have been...


Word of the Day
ambsace
  • Bad luck; misfortune.
  • The smallest amount possible or the most worthless thing.
The word 'ambsace' comes from a Latin word meaning 'both'.